Frontiers proposal. National Institute on Aging "bench to bedside: Estrogen as a case study"

Sanjay Asthana, Roberta Diaz Brinton, Victor W. Henderson, Bruce S. McEwen, John Morrison, Peter J. Schmidt

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

On 28-29 September 2004, the National Institute on Aging (NIA) convened scientists for a workshop on the aging female brain focused on translating into clinical practice discoveries concerning estrogens and progestogens. Workshop objectives were to examine effects of estrogen and progestogen on brain and cognitive function in relation to aging, to examine consistencies and apparent discrepancies between Women's Health Initiative Memory Study findings and other research on cognitive function, to determine whether additional hormone interventions could be developed in this area, and to offer advice on design of clinical trials for other interventions that might ameliorate cognitive aging. Following the workshop, participants joined by other interested scientists organized into regional work groups to continue the dialogue begun in Bethesda and to propose recommendations for NIA. The resulting recommendations, referred to as the "Frontiers Proposal for Estrogen and Cognitive Aging", acknowledge the persistence of critical gaps in our understanding of how decline in ovarian steroid secretion during reproductive aging and use of ovarian steroid hormone therapy affect normal brain function and risk for late-life neurodegenerative disorders such as Alzheimer's disease. There is a pressing need for preclinical, human, and integrated studies on the relationship between the menopausal transition and midlife exposures to estrogens, progestogens and related compounds, and risks for age-associated cognitive disorders. Research is also needed on better predictors of adverse cognitive outcomes, valid biomarkers for risks associated with hormone therapy use, enhanced tools for monitoring brain function and disease progression, and novel forms of therapy for improving long-term cognitive outcomes.

Original languageEnglish (US)
Pages (from-to)199-210
Number of pages12
JournalAge
Volume31
Issue number3
DOIs
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

National Institute on Aging (U.S.)
Estrogens
Progestins
Hormones
Education
Cognition
Brain
Steroids
Brain Diseases
Women's Health
Research
Neurodegenerative Diseases
Disease Progression
Alzheimer Disease
Therapeutics
Biomarkers
Clinical Trials

Keywords

  • Aging
  • Alzheimer's disease
  • Cognition
  • Dementia
  • Estrogen
  • Menopause
  • Progestogen

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Asthana, S., Brinton, R. D., Henderson, V. W., McEwen, B. S., Morrison, J., & Schmidt, P. J. (2009). Frontiers proposal. National Institute on Aging "bench to bedside: Estrogen as a case study". Age, 31(3), 199-210. https://doi.org/10.1007/s11357-009-9087-2

Frontiers proposal. National Institute on Aging "bench to bedside : Estrogen as a case study". / Asthana, Sanjay; Brinton, Roberta Diaz; Henderson, Victor W.; McEwen, Bruce S.; Morrison, John; Schmidt, Peter J.

In: Age, Vol. 31, No. 3, 01.09.2009, p. 199-210.

Research output: Contribution to journalArticle

Asthana, S, Brinton, RD, Henderson, VW, McEwen, BS, Morrison, J & Schmidt, PJ 2009, 'Frontiers proposal. National Institute on Aging "bench to bedside: Estrogen as a case study"', Age, vol. 31, no. 3, pp. 199-210. https://doi.org/10.1007/s11357-009-9087-2
Asthana, Sanjay ; Brinton, Roberta Diaz ; Henderson, Victor W. ; McEwen, Bruce S. ; Morrison, John ; Schmidt, Peter J. / Frontiers proposal. National Institute on Aging "bench to bedside : Estrogen as a case study". In: Age. 2009 ; Vol. 31, No. 3. pp. 199-210.
@article{cc22bfb4e9d54bbebebc77f2f43aa235,
title = "Frontiers proposal. National Institute on Aging {"}bench to bedside: Estrogen as a case study{"}",
abstract = "On 28-29 September 2004, the National Institute on Aging (NIA) convened scientists for a workshop on the aging female brain focused on translating into clinical practice discoveries concerning estrogens and progestogens. Workshop objectives were to examine effects of estrogen and progestogen on brain and cognitive function in relation to aging, to examine consistencies and apparent discrepancies between Women's Health Initiative Memory Study findings and other research on cognitive function, to determine whether additional hormone interventions could be developed in this area, and to offer advice on design of clinical trials for other interventions that might ameliorate cognitive aging. Following the workshop, participants joined by other interested scientists organized into regional work groups to continue the dialogue begun in Bethesda and to propose recommendations for NIA. The resulting recommendations, referred to as the {"}Frontiers Proposal for Estrogen and Cognitive Aging{"}, acknowledge the persistence of critical gaps in our understanding of how decline in ovarian steroid secretion during reproductive aging and use of ovarian steroid hormone therapy affect normal brain function and risk for late-life neurodegenerative disorders such as Alzheimer's disease. There is a pressing need for preclinical, human, and integrated studies on the relationship between the menopausal transition and midlife exposures to estrogens, progestogens and related compounds, and risks for age-associated cognitive disorders. Research is also needed on better predictors of adverse cognitive outcomes, valid biomarkers for risks associated with hormone therapy use, enhanced tools for monitoring brain function and disease progression, and novel forms of therapy for improving long-term cognitive outcomes.",
keywords = "Aging, Alzheimer's disease, Cognition, Dementia, Estrogen, Menopause, Progestogen",
author = "Sanjay Asthana and Brinton, {Roberta Diaz} and Henderson, {Victor W.} and McEwen, {Bruce S.} and John Morrison and Schmidt, {Peter J.}",
year = "2009",
month = "9",
day = "1",
doi = "10.1007/s11357-009-9087-2",
language = "English (US)",
volume = "31",
pages = "199--210",
journal = "GeroScience",
issn = "2509-2715",
publisher = "Springer International Publishing AG",
number = "3",

}

TY - JOUR

T1 - Frontiers proposal. National Institute on Aging "bench to bedside

T2 - Estrogen as a case study"

AU - Asthana, Sanjay

AU - Brinton, Roberta Diaz

AU - Henderson, Victor W.

AU - McEwen, Bruce S.

AU - Morrison, John

AU - Schmidt, Peter J.

PY - 2009/9/1

Y1 - 2009/9/1

N2 - On 28-29 September 2004, the National Institute on Aging (NIA) convened scientists for a workshop on the aging female brain focused on translating into clinical practice discoveries concerning estrogens and progestogens. Workshop objectives were to examine effects of estrogen and progestogen on brain and cognitive function in relation to aging, to examine consistencies and apparent discrepancies between Women's Health Initiative Memory Study findings and other research on cognitive function, to determine whether additional hormone interventions could be developed in this area, and to offer advice on design of clinical trials for other interventions that might ameliorate cognitive aging. Following the workshop, participants joined by other interested scientists organized into regional work groups to continue the dialogue begun in Bethesda and to propose recommendations for NIA. The resulting recommendations, referred to as the "Frontiers Proposal for Estrogen and Cognitive Aging", acknowledge the persistence of critical gaps in our understanding of how decline in ovarian steroid secretion during reproductive aging and use of ovarian steroid hormone therapy affect normal brain function and risk for late-life neurodegenerative disorders such as Alzheimer's disease. There is a pressing need for preclinical, human, and integrated studies on the relationship between the menopausal transition and midlife exposures to estrogens, progestogens and related compounds, and risks for age-associated cognitive disorders. Research is also needed on better predictors of adverse cognitive outcomes, valid biomarkers for risks associated with hormone therapy use, enhanced tools for monitoring brain function and disease progression, and novel forms of therapy for improving long-term cognitive outcomes.

AB - On 28-29 September 2004, the National Institute on Aging (NIA) convened scientists for a workshop on the aging female brain focused on translating into clinical practice discoveries concerning estrogens and progestogens. Workshop objectives were to examine effects of estrogen and progestogen on brain and cognitive function in relation to aging, to examine consistencies and apparent discrepancies between Women's Health Initiative Memory Study findings and other research on cognitive function, to determine whether additional hormone interventions could be developed in this area, and to offer advice on design of clinical trials for other interventions that might ameliorate cognitive aging. Following the workshop, participants joined by other interested scientists organized into regional work groups to continue the dialogue begun in Bethesda and to propose recommendations for NIA. The resulting recommendations, referred to as the "Frontiers Proposal for Estrogen and Cognitive Aging", acknowledge the persistence of critical gaps in our understanding of how decline in ovarian steroid secretion during reproductive aging and use of ovarian steroid hormone therapy affect normal brain function and risk for late-life neurodegenerative disorders such as Alzheimer's disease. There is a pressing need for preclinical, human, and integrated studies on the relationship between the menopausal transition and midlife exposures to estrogens, progestogens and related compounds, and risks for age-associated cognitive disorders. Research is also needed on better predictors of adverse cognitive outcomes, valid biomarkers for risks associated with hormone therapy use, enhanced tools for monitoring brain function and disease progression, and novel forms of therapy for improving long-term cognitive outcomes.

KW - Aging

KW - Alzheimer's disease

KW - Cognition

KW - Dementia

KW - Estrogen

KW - Menopause

KW - Progestogen

UR - http://www.scopus.com/inward/record.url?scp=69549133273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69549133273&partnerID=8YFLogxK

U2 - 10.1007/s11357-009-9087-2

DO - 10.1007/s11357-009-9087-2

M3 - Article

C2 - 19277902

AN - SCOPUS:69549133273

VL - 31

SP - 199

EP - 210

JO - GeroScience

JF - GeroScience

SN - 2509-2715

IS - 3

ER -